SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TransPharma Medical Ltd. Announces Successful Completion of Phase 1a Clinical Trial of ViaDerm-GLP1 Agonist Indicated for the Treatment of Type II Diabetes
Your Message